AkzoNobel and Evonik announce production joint venture for chlorine/potassium hydroxide solution

June 16, 2015

AkzoNobel and Evonik Industries have joined forces to build and operate a new membrane electrolysis facility for potassium hydroxide solution and chlorine in Germany. Start-up is expected by the end of 2017.

The 50-50 joint venture involves the construction and operation of a dedicated plant at AkzoNobel's existing site in Ibbenbüren. It will have an annual nameplate capacity of around 130,000 metric tons of potassium hydroxide solution and 82,000 metric tons of chlorine. This will strengthen the leading market positions of both companies. Financial details were not disclosed.

AkzoNobel will take over commercialization of chlorine and hydrogen at the new plant, and will process these products directly at the Ibbenbüren site. Evonik will take over the potassium hydroxide solution for commercialization and processing at its own site in Lülsdorf. This is where Evonik processes potassium hydroxide solution into potassium carbonate (potash).

"This investment in our chlor-alkali activities will make our business even more sustainable," explained Werner Fuhrmann, AkzoNobel's Executive Committee member responsible for Specialty Chemicals. "Not only will we secure the long-term supply of our customers with chlorine and hydrogen, but our environmental profile and operational efficiency will also further improve."

"The new joint venture will enable us to supply our customers with our potassium derivatives reliably in the long term," added Patrik Wohlhauser, member of Evonik's Executive Board. "At the same time, it means we're making a significant contribution to the environmentally-friendly and sustainable production of potassium derivatives."

All production of chlorine, potassium hydroxide and caustic lye using mercury-based amalgam electrolysis has to stop by the end of 2017 due to legislative requirements. The planned new membrane electrolysis plant will use a sustainable process which has a more positive environmental profile.

AkzoNobel is the market leader for industrial salt, merchant chlorine and chloromethanes in Europe, as well as holding a leading position for caustic lye in Europe. Evonik is a European market leader for potassium derivatives as well as a globally leading provider of alcoxides, which are manufactured in Lülsdorf, also by electrolysis.

The joint venture is subject to approval from the applicable regulatory authorities.

---
About AkzoNobel
AkzoNobel is a leading global paints and coatings company and a major producer of specialty chemicals. Calling on centuries of expertise, we supply industries and consumers worldwide with innovative products and sustainable technologies designed to meet the growing demands of our fast-changing planet. Headquartered in Amsterdam, the Netherlands, we have approximately 46,000 people in around 80 countries, while our portfolio includes well-known brands such as Dulux, Sikkens, International, Interpon and Eka. Consistently ranked as one of the leaders in the area of sustainability, we are committed to making life more liveable and our cities more human. Link to our Human Cities initiative

About Evonik
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and sustained value creation form the heart of our strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative strength and integrated technology platforms.

Evonik is active in more than 100 countries around the world. In fiscal 2014 more than 33,000 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €1.9 billion.

Not for publication - for more information

Media Relations AkzoNobel
T +31 20 502 7422                                                                      
Contact: Vivi Hollertt

Corporate Investor Relations
T: +31 20 502 7854
Contacts: Lindsey Sanders